KR840002006B1 - Process for preparing 5-sulfamoyl-othanilic acids - Google Patents

Process for preparing 5-sulfamoyl-othanilic acids Download PDF

Info

Publication number
KR840002006B1
KR840002006B1 KR1019810000524A KR810000524A KR840002006B1 KR 840002006 B1 KR840002006 B1 KR 840002006B1 KR 1019810000524 A KR1019810000524 A KR 1019810000524A KR 810000524 A KR810000524 A KR 810000524A KR 840002006 B1 KR840002006 B1 KR 840002006B1
Authority
KR
South Korea
Prior art keywords
sulfamoyl
ortanylate
furylmethyl
sodium
melting point
Prior art date
Application number
KR1019810000524A
Other languages
Korean (ko)
Other versions
KR830005193A (en
Inventor
스튜름 칼
무샤벡크 로만
Original Assignee
훽스트 아크티엔 게젤샤프트
하인리히 베커, 베른하르트 벡크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 훽스트 아크티엔 게젤샤프트, 하인리히 베커, 베른하르트 벡크 filed Critical 훽스트 아크티엔 게젤샤프트
Priority to KR1019810000524A priority Critical patent/KR840002006B1/en
Publication of KR830005193A publication Critical patent/KR830005193A/en
Application granted granted Critical
Publication of KR840002006B1 publication Critical patent/KR840002006B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/36Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

5-Sulfamoylorthanilic acids and their salts I [R = Cl, Br, Me, PhO or PhS (un)substituted with halo, alkyl, alkoxy, or CF3; Ar = furyl, thienyl , useful as diuretics, were prepd. Thus, 1,3-Cl2C6H2(SO2Cl)- 4,6 was treated with p-cresol in THF, NEt3, and NH3(g), the product 2,4,5-Cl2(H2NO2S)C6H2SO3C6H4Me-4 was esterified with PhOH, and the resulting 2,4,5-Cl(PhO)(N2NO2S)C6H2SO3H4Me -4 was treated with furfurylamine. This product (20% yield) I (R = PhO, Ar1 = 2-furyl) was sapond. with 2 N NaOH to give 75% I (R = PhO, R1 = 2-furyl).

Description

5-설파모일-오르타닐산의 제조방법Method for preparing 5-sulfamoyl-ortanylic acid

본 발명은 염분 배설제로 유용한 다음 일반식(I)의 5-설파모일-오르타닐산 화합물 및 이의 생리학적으로 허용되는 염의 제조방법에 관한 것이다.The present invention relates to a 5-sulfamoyl-ortanyl acid compound of formula (I) and a physiologically acceptable salt thereof useful as a salt excretion agent.

Figure kpo00001
Figure kpo00001

상기식에서In the above formula

R은 각각 탄소수 10이하인 알킬, 알케닐, 사이클로알킬 또는 사이클로알킬알킬이거나 페닐이고 ; Ar은 페닐, 티에닐 또는 푸릴이다.R is alkyl, alkenyl, cycloalkyl or cycloalkylalkyl or phenyl, each having up to 10 carbon atoms; Ar is phenyl, thienyl or furyl.

R이 알킬 또는 알케닐일 경우 이는 직쇄 또는 측쇄일 수 있다. 알킬 또는 알킬렌은 탄소수 4 내지 6인 것이 바람직하다.If R is alkyl or alkenyl it may be straight or branched. The alkyl or alkylene preferably has 4 to 6 carbon atoms.

R이 사이클릭기일 경우 5원 내지 8원환이 바람직하다. 따라서 R은 특히 사이클로펜틸, 사이클로헥실, 사이클로헵틸, 사이클로헥실메틸, n-부틸, 이소부틸, n-펜틸 또는 -n헥실일 수 있다.When R is a cyclic group, a 5-8 membered ring is preferable. Thus R can in particular be cyclopentyl, cyclohexyl, cycloheptyl, cyclohexylmethyl, n-butyl, isobutyl, n-pentyl or -nhexyl.

Ar로서는 2-푸릴 및 2-티에닐이 가장 바람직하다.As Ar, 2-furyl and 2-thienyl are most preferable.

생리학적으로 허용되는 모든 양이온, 특히 알칼리금속 또는 알칼리토금속이온,All physiologically acceptable cations, especially alkali or alkaline earth metal ions,

본 발명의 일반식 (I) 화합물은 다음과 같은 방법으로 제조한다 ; 즉General formula (I) compound of this invention is manufactured by the following method; In other words

a) 다음 일반식(II)의 에스테르를 알칼리성 조건하에서 비누화시키거나 ;a) saponifying the ester of the following general formula (II) under alkaline conditions;

b) 다음 일반식(III)의 화합물 또는 이의 염을 다음 일반식(IV)의 아민과 반응시키거나b) reacting a compound of formula (III) or a salt thereof with an amine of formula (IV)

c) 다음 일반식(V)의 화합물 또는 이의 염을 산화시켜 설폰을 얻고, 임의로 생성된 화합물을 유리산 또는 염으로 전환시킴으로서 일반식(I)의 화합물 및 그의 염을 제조할 수 있다.c) The compounds of formula (I) and salts thereof can be prepared by oxidizing the following compounds of formula (V) or salts thereof to obtain sulfones and optionally converting the resulting compounds into free acids or salts.

Figure kpo00002
Figure kpo00002

상기식에서In the above formula

R 및 Ar은 전술한 바와 같고, X는 할로겐이고,R and Ar are as described above, X is halogen,

Z 는 아릴이며, Y는 -S-또는-SO-이다.Z is aryl and Y is -S- or-SO-.

반응 a)에서, 출발물질인 일반식(II)화합물중의 기 Z로서는 대체로 방향족 기가 적절하나, 공업적인 합성을 위해서는 제조가 용이한 페닐 또는 크레실 에스테르를 사용하는 것이 특히 유리하다.In reaction a), aromatic groups are generally suitable as group Z in the general formula (II) compound as starting material, but for industrial synthesis, it is particularly advantageous to use phenyl or cresyl esters which are easy to prepare.

에스테르의 알칼리성 비누화 반응은 무기염기, 특히 과량의 1N 내지 5N수산화나트륨 또는 수산화칼륨 용액을 사용하여 수성 매질중에서 수행하는 것이 바람직하다.The alkaline saponification reaction of the ester is preferably carried out in an aqueous medium using an inorganic base, in particular an excess of 1N to 5N sodium hydroxide or potassium hydroxide solution.

예를들어, 페닐 또는 크레실 에스테르를 2N 수산화나트륨 또는 수산화칼륨 수용액을 사용하여 증기 욕상에서 1시간에 걸쳐 완전히 비누화시킬 수 있다. 비누화 용액을 실온에서 무기산(바람직하게는 염사) 또는 유기산(예 ; 아세트산)으로 중화시키면 최종 생성물이 즉시 각각 나트륨 또는 칼륨염 형태로 동명한 비누화용액으로부터 결정화되어 석출된다. 일반적으로 칼륨염이 상응하는 나트륨염 보다 물에 더 잘 녹지 않는다. 비누화 반응에서 유리된 페놀은 어떤 경우, 특히 페닐에스테르 대신 크레실, 크실릴, 니트로페닐, 클로로페닐 또는 나프릴에스테르를 출발물질로 사용한 경우에는 반응 생성물과 함께 침전된다.For example, phenyl or cresyl esters can be fully saponified over 1 hour in a steam bath using 2N aqueous sodium or potassium hydroxide solution. The saponification solution is neutralized at room temperature with an inorganic acid (preferably a saline) or an organic acid (eg acetic acid) and the final product immediately crystallizes out from the saponified solution in the form of sodium or potassium salts respectively. In general, potassium salts are less soluble in water than the corresponding sodium salts. The phenol liberated in the saponification reaction is precipitated with the reaction product in some cases, especially when cresyl, xylyl, nitrophenyl, chlorophenyl or napryl esters are used as starting materials instead of phenyl esters.

이러한 페놀의 잔류물은 침전을 유기용매로 철저히 세척함으로써 제거할 수 있다. 이를 위해서는 생성물이 거의 용해하지 않는 용매, 예를들면 에탄올, 이소프로판올, 디에틸에테르, 디이소프로필에테르, 아세톤 또는 테트라 하이드로푸란을 사용한다. 용매 세척후 잔유할 수 있는 극미량의 페놀은 생성물을 수성알콜로 재결정화 시킴으로써 제거할 수 있다.Residues of these phenols can be removed by washing the precipitate thoroughly with an organic solvent. For this purpose, solvents in which the product hardly dissolves are used, for example ethanol, isopropanol, diethyl ether, diisopropyl ether, acetone or tetra hydrofuran. Trace amounts of phenol that may remain after solvent washing can be removed by recrystallization of the product with aqueous alcohol.

일반식(II)의 출발물질은 독일연방공화국 공개공보 제2,718,871호에 기술된 다음 구조식(VI)의 2,4-디콜로로-5-설파모일-벤젠설폰산 아릴에스테르를 다음과 같Starting materials of the general formula (II) include the following 2,4-dicholo-5-sulfamoyl-benzenesulfonic acid aryl esters of the following formula (VI) as described in JP 2,718,871.

Figure kpo00003
Figure kpo00003

반응 b)에서는, 일반식(III)의 출발물질로 X가 불소 또는 염소인 화합물의 알킬리 금속염을 사용하는 것이 바람직하다. 일반식(IV)의 아민과의 반응은 X가 불소일 경우 80°내지 100℃에서 수행하는 것이 유리하며 X가 염소일 경우 120°내지 140℃에서 수행하는 것이 유리하다. 형성된 할로겐화 수소를 결합시키기 위해서는 탄산나트륨, 탄산칼륨 또는 3급아민 같은 산결합제를 반응 용기에 가할 수 있다. 산결합제로서는 일반식(IV)의 염기 자체를 2-몰 내지 3-몰 과량으로 사용하는 것이 특히 유리하다. 이 반응에 사용되는 용매는 특히 강한 극성이며 수-혼화성인 유기용매(예 : 디메틸설폭사이드 또는 디메틸포름아미드)이다.In reaction b), it is preferable to use the alkyl metal salt of the compound whose X is fluorine or chlorine as a starting material of general formula (III). The reaction with the amine of general formula (IV) is advantageously carried out at 80 ° to 100 ° C. when X is fluorine and at 120 ° to 140 ° C. when X is chlorine. To bind the formed hydrogen halide, an acid binder such as sodium carbonate, potassium carbonate or tertiary amine may be added to the reaction vessel. As the acid binder, it is particularly advantageous to use the base itself of the general formula (IV) in an excess of 2-mol to 3-mol. Solvents used in this reaction are particularly strong polar and water-miscible organic solvents such as dimethylsulfoxide or dimethylformamide.

반응이 완결된 후, 용매 및 과량의 아민을 증류하여 완전히 게거하는 것이 유리After the reaction is complete, it is advantageous to distill off the solvent and excess amine to completely remove it.

일반식(III)의 출발물질은 일반식(VII)의 화합물을 H2O2또는 유기과산으로 산화시킨 후 알칼리성 비누화시켜 간단한 방법으로 수득할 수 있다.Starting materials of the general formula (III) can be obtained by a simple method by oxidizing the compound of the general formula (VII) with H 2 O 2 or organic peracid and then alkaline saponification.

반응 c)에서는, 일반식(V)의 티오에테르 또는 설폭사이드를 산화시켜 상응하는 설폰을 수득한다. Ar이 페닐 또는 티에닐일 경우 이 산화반응은 빙초산 중에서 퍼하이드롤을 사용하거나 과세아세트산/빙초산을 사용하여 20 내지 60℃에서 수행하는 것이 유리하다. Ar이 푸릴인 일반식(V)의 화합물은 묽은 용액 내에서 이론량의 과산을 사용하여 실온에서 산화시키는 것이 유리하다. 이 반응에 적절한 용매의 예에는 메틸렌 클로라이드와 디메틸포름아미드의 혼합물이 있고 적절한 산화제의 예에는 3-클로로 과벤조산이 있다. 1NKHCO3또는 1N NaHCO3수용액으로 재결정시킨 후 용매를 제거함으로써 최종 생성물을 유리시키는 것이 유리하다.In reaction c), thioethers or sulfoxides of general formula (V) are oxidized to give the corresponding sulfones. If Ar is phenyl or thienyl, this oxidation reaction is advantageously carried out at 20 to 60 ° C. with perhydrool in glacial acetic acid or with peracetic acid / glacial acetic acid. Compounds of formula (V) wherein Ar is furyl are advantageously oxidized at room temperature using theoretical amounts of peracids in dilute solutions. Examples of suitable solvents for this reaction include mixtures of methylene chloride and dimethylformamide and examples of suitable oxidants are 3-chloroperbenzoic acid. It is advantageous to liberate the final product by removing the solvent after recrystallization with 1NKHCO 3 or 1N NaHCO 3 aqueous solution.

일반식(V)의 출발물질은 일반식(VIII)의 설폰산 아릴에스테르를 비누화시키거나, 또는 산화시켜 설폭사이드를 얻은 후 이를 비누화시켜 수득할 수 있다.Starting materials of general formula (V) may be obtained by saponifying or oxidizing sulfonic acid aryl esters of general formula (VIII) to obtain sulfoxides followed by saponification thereof.

본 발명에 따른 화합물은 알칼리금속, 알칼리토금속 또는 암모늄염의 형태일 경우 쉽게 결정화되는 무색의 안정한 물질이다. 이들은 실온에서 특히 물에 잘 용해하지 않는다. 따라서 이 화합물들은 물 또는 유기 용매(예 : 알콜, 아세톤, 디옥산, 테트라하이드로푸란, 또는 디메틸포름아미드)를 함유하는 물로부터 특히 잘 재정결화될 수 있다. 이들 금속염 중에서 나트륨염이 물에 가장 잘 녹는다. 따라서 이들은 적절한 수용성 염과 함께 수용액중에서 이중분해 시킴으로써 금속염으로 특히 쉽게 전환될 수 있다.The compounds according to the invention are colorless, stable substances which readily crystallize when in the form of alkali metal, alkaline earth metal or ammonium salts. They do not dissolve particularly well in water at room temperature. These compounds can thus be particularly well recrystallized from water or water containing organic solvents such as alcohols, acetone, dioxane, tetrahydrofuran, or dimethylformamide. Of these metal salts, sodium salts dissolve best in water. They can thus be converted particularly easily to metal salts by double decomposition in aqueous solution with suitable water soluble salts.

하이드록시아민(예 : 모노-, 디-, 트리-에탄올아민) 또는 글루코스아민을 함유하는 염은 나트륨 염보다 물에 훨씬 잘 용해할 수 있다.Salts containing hydroxyamines (eg mono-, di-, tri-ethanolamine) or glucoseamines are much more soluble in water than sodium salts.

화합물은 유리설폰산의 형태로 유리될 수도 있다. 유리설폰산은 나트륨염을 5N HCl로 처리함으로써 유리시킬 수 있다. 그러나 유리산은 특히 Ar이 푸릴일 경우에는 안정하지 못하다.The compound may be liberated in the form of freesulfonic acid. Freesulfonic acid can be liberated by treating sodium salts with 5N HCl. However, free acids are not stable, especially when Ar is furyl.

따라서 유리산은 치료용으로 덜 적절하다. 한편 나트륨 및 칼륨염이 약제의 제조에 특히 적절하다. 염기성의 칼륨-함유 화합물(예 : 아밀로라이드 또는 트리알테렌)을 함유하는 염, 또는 염기성의 고혈압치료제(예 : 클로니딘, 디하이드랄라진 또는 구아네티딘)을 함유하거나 β-차단제(예 : 프로프라놀롤, 티몰롤, 펜부톨롤 또는 핀돌롤)을 함유하는 염이 또한 특히 약제학적으로 중요하다.Free acid is therefore less suitable for treatment. Meanwhile sodium and potassium salts are particularly suitable for the preparation of medicaments. Salts containing basic potassium-containing compounds (e.g. amylolide or trialterene), or basic antihypertensive agents (e.g. clonidine, dihydralazine or guanetidine) or β-blockers (e.g. propranolol, Salts containing timolol, fenbutolol or pindolol) are also of particular pharmaceutical importance.

본 발명 화합물은 푸로세비드 이뇨제 형태의 염분 배설제로 탁월한 효능을 나타낸다. 이런 형태의 공지의 화합물과 비교하여 본 발명 화합물은 특히 칼슘의 제거율이 낮고 명백히 효과적인 요산 배설제라는 점에서 특징이 있다.The compounds of the present invention show excellent efficacy as salt excretion agents in the form of furosevid diuretics. Compared with known compounds of this type, the compounds of the present invention are particularly characterized in that they have a low removal rate of calcium and are clearly effective uric acid excretion agents.

본 발명 화합물은 특히 0.1 내지 50mg의 활성성분을 함유하는 정제, 당의정 또는 캅셀제 형태로 경구투여하는 것이 인체치료에 특히 적절하며 또한 0.1 내지 10mg의 활성성분을 함유하는 주사용 수용액을 사용하여 정맥내 투여할 수도 있다.The compound of the present invention is particularly suitable for human treatment, especially orally administered in the form of tablets, dragees or capsules containing 0.1 to 50 mg of active ingredient, and also administered intravenously using an aqueous solution for injection containing 0.1 to 10 mg of active ingredient. You may.

[실시예 1]Example 1

나트륨 N-(2-푸릴메틸)-4-클로로헥실설포닐-5-설파모일-오르타닐레이트Sodium N- (2-furylmethyl) -4-chlorohexylsulfonyl-5-sulfamoyl-ortanylate

55.5g(0.1몰)의 N-(2-푸릴메틸)-4-사이클로 헥실설포닐-5-설파모일-오55.5 g (0.1 mole) N- (2-furylmethyl) -4-cyclohexylsulfonyl-5-sulfamoyl-o

수득량 : 44g(이론치의 88%)Yield: 44 g (88% of theory)

융점 : 300℃(분해)Melting Point: 300 ℃ (Decomposition)

[실시예 2]Example 2

칼륨 N-(2-푸릴메틸)-4-사이클로헥실설포닐-5-설파모일-오르라닐레이트Potassium N- (2-furylmethyl) -4-cyclohexylsulfonyl-5-sulfamoyl-orlanylate

90%의 3-클로로과벤조산 42g(0.22몰)을, 교반하면서 실온에서 1.0ℓ의 디메틸포름아미드에 녹인 48.5g(0.1몰)의 칼륨 N-(2-푸릴메틸)-4-사이클로헥실 메르캅토-5-설파모일-오르타닐레이트[융점 : 227℃(분해), 물로 재결정] 용액에 조금씩 가한다. 실온에서 철야 방치한 후 디메틸포름아미드를 진공하에 제거하고 잔사에 1.0ℓ의 물을 가한후 2N KOH를 가하여 pH를 8로 조절한다. 15℃에서 1시간 방치한 후 결정형태로 분리된 최중 생성물을 여과한후 물로 재결정시키고 활성탄을 가하여 정제한다.48.5 g (0.1 mole) of potassium N- (2-furylmethyl) -4-cyclohexyl mercapto- dissolved in 90 g of 3-chloroperbenzoic acid 42 g (0.22 mole) dissolved in 1.0 L of dimethylformamide at room temperature with stirring. 5-Sulfamoyl-ortanylate (melting point: 227 ° C. (decomposition), recrystallized from water) was added to the solution little by little. After standing at room temperature overnight, dimethylformamide was removed under vacuum, 1.0 L of water was added to the residue, and then 2N KOH was added to adjust the pH to 8. After standing at 15 ° C. for 1 hour, the intermediate product isolated in crystalline form was filtered, recrystallized with water, and purified by adding activated carbon.

수득량 : 41g(이론치의 79%)Yield: 41 g (79% of theory)

융점 : 305℃(분해)Melting Point: 305 ℃ (Decomposition)

[실시예 3]Example 3

나트륨 N-(2-티에닐메틸)-4-사이클로헥실설포닐-5-설파모일-오르타닐Sodium N- (2-thienylmethyl) -4-cyclohexylsulfonyl-5-sulfamoyl-ortanyl

57.1g(0.1몰)의 N-(2-티에닐메틸)-4-사이클로헥실설포닐-5-설파모일-오르타닐산 페닐에스테르(융점 : 193℃)를 실시예 1과 유사한 방법으로 2N NaOH로 검화시킨 후 최종 생성물을 실시예 1과 같이 유리시킨다.57.1 g (0.1 mole) of N- (2-thienylmethyl) -4-cyclohexylsulfonyl-5-sulfamoyl-ortanylic acid phenylester (melting point: 193 ° C) was converted to 2N NaOH in a similar manner as in Example 1. After saponification, the final product is liberated as in Example 1.

수득량 : 48.5g(이론치의 84%)Yield: 48.5 g (84% of theory)

융점 : 310℃(분해)Melting Point: 310 ℃ (Decomposition)

[실시예 4]Example 4

나트륨 N-벤질-4-사이클로헥실설포닐-5-설파모일-오르타닐레이트Sodium N-benzyl-4-cyclohexylsulfonyl-5-sulfamoyl-ortanylate

56.4g(0.1몰)의 N-벤질-4-사이클로헥실-설포닐-5-설파모일-오르타닐산 페닐에스테르를 실시예 1과 유사한 방법으로 0.4ℓ의 2N NaOH로 검화시키고 최종 생성물을 30%의 에탄올로 재결정시킨다.56.4 g (0.1 mol) of N-benzyl-4-cyclohexyl-sulfonyl-5-sulfamoyl-ortanylic acid phenylester was purified with 0.4 L of 2N NaOH in a similar manner to Example 1 and the final product was 30% Recrystallize from ethanol.

수득량 : 43g(이론치의 84%)Yield: 43 g (84% of theory)

융점 : 296℃(분해)Melting Point: 296 ° C (Decomposition)

[실시예 5]Example 5

칼륨 N-(2-푸릴메틸)-4-페닐설포닐-5-설파모일-오르타닐레이트Potassium N- (2-furylmethyl) -4-phenylsulfonyl-5-sulfamoyl-ortanylate

45.0g(0.1몰)의 칼륨 2-클로로-4-페닐설포닐-5-설파모일 벤젠설포네이트를, 0.1ℓ의 푸르푸릴 아민과 0.1ℓ의 디메틸 설폭사이드와의 혼합물과 함께 125 내지 130℃에서 2시간 교반한다. 과량의 푸르푸릴아민과 디메틸 설폭사이드를 진공하에 증류하고 잔사에 0.1ℓ의 물을 가한 후 5N HCl을 가하여 혼합물의 pH를 7로 조절한다. 실온에서 1시간 방치한 후 결정형태로 침전된 최종 생성물을 여과하고 물로 재결정시켜45.0 g (0.1 mole) of potassium 2-chloro-4-phenylsulfonyl-5-sulfamoyl benzenesulfonate at 125-130 ° C. with a mixture of 0.1 L of furfuryl amine and 0.1 L of dimethyl sulfoxide Stir for 2 hours. Excess furfurylamine and dimethyl sulfoxide are distilled under vacuum, 0.1 L of water is added to the residue, and 5N HCl is added to adjust the pH of the mixture to 7. After standing at room temperature for 1 hour, the final product precipitated in crystalline form was filtered and recrystallized with water.

수득량 : 35g(이론치의 70%)Yield: 35 g (70% of theory)

융점 : 270℃(분해)Melting Point: 270 ° C (Decomposition)

[실시예 6]Example 6

나트륨 N-(2-푸릴메틸)-4-사이클로헵틸설포닐-5-설파모일-오르타닐레이트Sodium N- (2-furylmethyl) -4-cycloheptylsulfonyl-5-sulfamoyl-ortanylate

56.0g(0.1몰)의 N-(2-푸릴메틸)-4-사이클로헵틸설포닐-5-설파모일-오르타닐산 페닐 에스테르(융점 : 163℃, 메탄올로 재결정)를 실시예 1과 유사한 방법으로 수산화나트륨 용액으로 검화시키고 최종 생성물을 실시예 1과 같이 유리시킨다.56.0 g (0.1 mol) of N- (2-furylmethyl) -4-cycloheptylsulfonyl-5-sulfamoyl-ortanylic acid phenyl ester (melting point: 163 DEG C, recrystallized from methanol) was prepared in a similar manner to Example 1. It is saponified with sodium hydroxide solution and the final product is liberated as in Example 1.

수득량 : 44g(이론치의 86%)Yield: 44 g (86% of theory)

융점 : 284℃(분해)Melting Point: 284 ℃ (Decomposition)

[실시예 7]Example 7

칼륨 N-(2-푸릴메틸)-4-n-부틸설포닐-5-설파모일-오르타닐레이트Potassium N- (2-furylmethyl) -4-n-butylsulfonyl-5-sulfamoyl-ortanylate

45.8g(0.1몰)의 칼륨 N-(2-푸릴메틸)-4-n-부틸메르캅토-5-설파모일-오르타닐레이트(융점 : 245℃물로 재결정)를 0.1ℓ의 디메틸설폭사이드에 녹이고 이 용액을 0.3ℓ의 메틸렌클로라이드로 회석한 후 90%의 3-클로로과벤조산 48g(0.25몰)을 실온에서 교반하며 가하고 실온에서 철야 방치한다. 용매를 진공하에 제거하고 잔사를 0.3ℓ의 따뜻한 1N KHNO3로 처리하여 3-클로로벤조산을 제거한 후 녹지 않은채 남아있는 최종 생성물을 물로 재결정시켜 정제한다.45.8 g (0.1 mol) of potassium N- (2-furylmethyl) -4-n-butylmercapto-5-sulfamoyl-ortanylate (melting point: recrystallized from 245 DEG C) was dissolved in 0.1 L of dimethyl sulfoxide. The solution was diluted with 0.3 L of methylene chloride, and then 48 g (0.25 mol) of 90% of 3-chloroperbenzoic acid was added with stirring at room temperature and left overnight at room temperature. The solvent is removed in vacuo and the residue is treated with 0.3 L of warm 1N KHNO 3 to remove 3-chlorobenzoic acid and then purified and recrystallized from water with the final product remaining undissolved.

수득량 : 24g(이론치의 49%)Yield: 24 g (49% of theory)

융점 : 330℃(분해)Melting Point: 330 ° C (Decomposition)

[실시예 8]Example 8

0.1몰의 N-(2-푸릴메틸)-4-n-프로필설포닐-5-설파모일-오르타닐산 페닐 에스테르(융점 : 145℃, 메탄올로 재결정)를 실시예 1과 유사한 방법으로 NaOH로 검화시키고 최종 생성물을 실시예 1과 같은 방법으로 유리시킨다.0.1 mole of N- (2-furylmethyl) -4-n-propylsulfonyl-5-sulfamoyl-ortanylic acid phenyl ester (melting point: 145 DEG C, recrystallized from methanol) was saponified with NaOH in a similar manner to Example 1 And the final product is liberated in the same manner as in Example 1.

수득량 : 35g(이론치의 76%)Yield: 35 g (76% of theory)

융점 : 320℃(분해)Melting Point: 320 ℃ (Decomposition)

[실시예 9]Example 9

나트륨 N-(푸릴메틸)-4-사이클로펜틸설포닐-5-설파모일-오르타닐레이트Sodium N- (furylmethyl) -4-cyclopentylsulfonyl-5-sulfamoyl-ortanylate

54.1g(0.1몰)의 N-(2-푸릴메틸-4-사이클로펜틸설포닐-5-설파모일-오르타닐산 페닐 에스테르(융점 : 169℃, 메탄올/디메틸포름아미드(1 : 2)로 재결정)를 실시예 1과 유사하게 NaOH로 검화시킨다. HCl을 가하여 pH를 7로 조절함으로써 침전된 최종 생성물을 여과기상에서 물로 세척하고 에탄올로 세척한후 90℃에서 건조시킨다.54.1 g (0.1 mol) of N- (2-furylmethyl-4-cyclopentylsulfonyl-5-sulfamoyl-ortanylic acid phenyl ester (melting point: 169 DEG C, recrystallized from methanol / dimethylformamide (1: 2)) The saponified final product is washed with water on a filter, washed with ethanol and then dried at 90 ° C. by adjusting the pH to 7 by adding HCl.

수득량 : 40g(이론치의 82%)Yield: 40 g (82% of theory)

융점 : 285℃(분해)Melting Point: 285 ° C (Decomposition)

[실시예 10]Example 10

칼륨 N-(2-푸릴메틸)-4-알릴설포닐-5-설파모일-오르타닐레이트Potassium N- (2-furylmethyl) -4-allylsulfonyl-5-sulfamoyl-ortanylate

51.3g(0.1몰)의 N-(2-푸릴메틸)-4-알릴메르캅토-5-설파모일-오르타닐산 에스테르(융점 : 138℃)를 0.4ℓ의 2N KOH와 함께 스팀욕상에서 교반하며 30분간51.3 g (0.1 mole) of N- (2-furylmethyl) -4-allyl mercapto-5-sulfamoyl-ortanyl acid ester (melting point: 138 ° C.) was stirred with 0.4 L of 2N KOH in a steam bath. Minute

반응 용액을 실온으로 냉각시키고 5N HCl로 중화시킨 후 혼액액을 증발. 건고시키고 잔사를 0.1ℓ뜨거운 디메틸포름아미드로 추출한다음 0.4ℓ의 디이소프로필에테르를 가하여 여과 용액으로 부터 결정형태의 최종생성물을 침전시킨다.The reaction solution was cooled to room temperature, neutralized with 5N HCl, and the mixture was evaporated. Dry and extract the residue with 0.1 L hot dimethylformamide and add 0.4 L diisopropyl ether to precipitate the final product in crystalline form from the filtrate solution.

수득량 : 35g(이론치의 74%)Yield: 35 g (74% of theory)

융점 : 125℃(분해)Melting Point: 125 ℃ (Decomposition)

[실시예 11]Example 11

나트륨 N-(2-푸릴메틸)-4-사이클로헥실메틸설포닐-5-설파모일-오르타닐레이트Sodium N- (2-furylmethyl) -4-cyclohexylmethylsulfonyl-5-sulfamoyl-ortanylate

56.7g(0.1몰)의 N-(2-푸릴메틸)-4-사이클로헥실 메틸설포닐-5-설파모일 -오르타닐산 페닐 에스테르(융점 : 152℃, 메탄올로 재결정)를 0.4ℓ의 2N NaOH와 함께 스팀욕상에서 교반하며 45분간 가온하고 최종 생성물을 실시예 1과 유사한 방법으로 유리시킨다.56.7 g (0.1 mol) of N- (2-furylmethyl) -4-cyclohexyl methylsulfonyl-5-sulfamoyl-ortanylic acid phenyl ester (melting point: 152 DEG C, recrystallized from methanol) with 0.4 L of 2N NaOH Stir together in a steam bath and warm for 45 minutes and liberate the final product in a similar manner to Example 1.

수득량 : 46g(이론치의 90%)Yield: 46 g (90% of theory)

융점 : 350℃(분해)Melting Point: 350 ℃ (Decomposition)

[실시예 12]Example 12

나트륨 N-(2-푸릴메틸)-4-메틸설포닐-5-설파모일-오르타닐레이트Sodium N- (2-furylmethyl) -4-methylsulfonyl-5-sulfamoyl-ortanylate

48.6g(0.1몰)의 N-(2-푸릴메틸)-4-메틸설포닐-5-설파모일-오르타닐산 페닐 에스테르(융점 : 175℃, 메탄올로 재결정)를 0.4ℓ의 2N KOH와 함께 스팀욕상에서 1시간 가온하고 최종 생성물을 실시예 1과 유사한 방법으로 유리시킨다.48.6 g (0.1 mole) of N- (2-furylmethyl) -4-methylsulfonyl-5-sulfamoyl-ortanyl acid phenyl ester (melting point: 175 ° C., recrystallized from methanol) was steamed with 0.4 L of 2N KOH Warm for 1 hour in the bath and liberate the final product in a similar manner to Example 1.

수득량 : 36.5g(이론치의 81%)Yield: 36.5 g (81% of theory)

융점 : 225℃(분해)Melting Point: 225 ℃ (Decomposition)

[실시예 13]Example 13

나트륨 N-(2-티에닐메틸)-4-사이클로펜틸설포닐-5-설파모일-오르타닐레이트Sodium N- (2-thienylmethyl) -4-cyclopentylsulfonyl-5-sulfamoyl-ortanylate

55.7g(0.1몰)의 N-(2-티에닐메틸)-4-사이클로펜틸설포닐-5-설파모일-오르타닐산 페닐에스테르(융점 : 194℃, 메탄올로 재결정)를 0.4ℓ의 2N NaOH와 함께 스팀욕상에서 1시간 가열하여 검화시키고 최종 생성물을 실시예 1과 유사한 방법으로 유리시킨다.55.7 g (0.1 mol) of N- (2-thienylmethyl) -4-cyclopentylsulfonyl-5-sulfamoyl-ortanylic acid phenyl ester (melting point: 194 DEG C, recrystallized from methanol) was mixed with 0.4 L of 2N NaOH. The mixture is heated for 1 hour in a steam bath to be saponified and liberated in the same manner as in Example 1.

수득량 : 42.5g(이론치의 85%)Yield: 42.5 g (85% of theory)

융점 : 278℃(분해)Melting Point: 278 ℃ (Decomposition)

[실시예 14]Example 14

나트륨 N-(2-푸릴메틸)-4-n-헥실설포닐-5-설파모일-오르타닐레이트Sodium N- (2-furylmethyl) -4-n-hexylsulfonyl-5-sulfamoyl-ortanylate

48.7g(0.1몰)의 N-(2-푸릴메틸)-4-n-헥실설포닐-5-설파모일-오르타닐산 페닐 에스테르(융점 : 140℃, 메탄올로 재결정)를 0.4ℓ의 2N NaOH와 함께 45분간 환류하에 가열하고 실온에서 5N HCl을 가하여 투명한 반응 용액의 pH를 7로 조절한후 1시간후 결정 형태로 침전된 최종 생성물을 여과하고 무수 에탄올로 세척한 다음 90℃에서 건조시킨다.48.7 g (0.1 mol) of N- (2-furylmethyl) -4-n-hexylsulfonyl-5-sulfamoyl-ortanylic acid phenyl ester (melting point: 140 DEG C, recrystallized from methanol) was mixed with 0.4 L of 2N NaOH. The mixture was heated under reflux for 45 minutes and adjusted to pH 7 of the clear reaction solution by adding 5N HCl at room temperature. After 1 hour, the final product precipitated in crystalline form was filtered, washed with anhydrous ethanol and dried at 90 ° C.

수득량 : 43g(이론치의 85%)Yield: 43 g (85% of theory)

융점 : 209℃(분해)Melting Point: 209 ℃ (Decomposition)

상술한 화합물 이외에, 다음의 화합물들도 유사한 방법으로 수득할 수 있다 :In addition to the above-mentioned compounds, the following compounds can also be obtained by a similar method:

칼륨 N-(2-푸릴메틸)-4-에틸설포닐-5-설파모일-오르타닐레이트, 나트륨 N-(2-티에틸메틸)-4-에틸설포닐-5-설파모일-오르타닐레이트, 나트륨 N-(2-푸릴메틸)-4-이소프로필설포닐-5-설파모일-오르타닐레이트, 나트륨 N-(2-티에닐메틸)-4-n-프로필설포닐-5-설파모일-오르타닐레이트, 칼륨 N-(2-티에닐메틸) -4-n-부틸설포닐-5-설파모일-오르타닐레이트, 나트륨 N-벤질-4-n-부틸설포닐 -5-설파모일-오르타닐레이트, 칼륨 N-(2-푸릴메틸)-4-이소부틸설포닐-5-설파모일-오르타닐레이트, 칼륨 N-(2-티에닐메틸)-4-이소부틸설포닐-5-설파모일-오르타닐레이트, 나트륨 N-(2-티에닐메틸)-4-알릴설포닐-5-설파모일-오르타닐레이트, 칼륨 N-(2-푸릴메틸)-4-n-펜틸설포닐-5-설파모일-오르타닐레이트, 칼륨 N-(2-푸릴메틸)-4-n-옥틸설포닐-5-설파모일-오르타닐레이트, 칼륨 N-(2-푸릴메틸)-4-사이클로프로필설포닐-5-설파모일-오르타닐레이트, 나트륨 N-(2-푸릴메틸)-4-사이클로프로필설포닐-오르타닐레이트, 나트륨 N-(2-푸릴메틸)-4-사이클로부틸메틸설포닐-5-설파모일-오르타닐레이트, 칼륨 N-(2-푸릴메틸)-4-사이클로펜틸메틸설포닐-5-설파모일-오르타닐레이트, 나트륨 N-(3-푸릴메틸) -4-사이클로헥실설포닐-5-설파모일-오르타닐레이트, 나트륨 N-(2-티에닐메틸) -4-사이클로헵틸설포닐-5-설파모일-오르타닐레이트, 칼륨 N-(2-푸릴메틸)-4-사이클로옥틸설포닐-5-설파모일-오르타닐레이트, 및 나트륨 N-(2-푸릴메틸)-5-사이클로옥틸메틸설포닐-5-설파모일-오르타닐레이트.Potassium N- (2-furylmethyl) -4-ethylsulfonyl-5-sulfamoyl-ortanylate, sodium N- (2-thiethylmethyl) -4-ethylsulfonyl-5-sulfamoyl-ortanylate Sodium N- (2-furylmethyl) -4-isopropylsulfonyl-5-sulfamoyl-ortanylate, sodium N- (2-thienylmethyl) -4-n-propylsulfonyl-5-sulfamoyl -Ortanylate, potassium N- (2-thienylmethyl) -4-n-butylsulfonyl-5-sulfamoyl-ortanylate, sodium N-benzyl-4-n-butylsulfonyl -5-sulfamoyl -Ortanylate, potassium N- (2-furylmethyl) -4-isobutylsulfonyl-5 -sulfamoyl-ortanylate, potassium N- (2-thienylmethyl) -4-isobutylsulfonyl-5 Sulfamoyl-ortanylate, sodium N- (2-thienylmethyl) -4-allylsulfonyl-5-sulfamoyl-ortanylate, potassium N- (2-furylmethyl) -4-n-pentylsul Ponyl-5-sulfamoyl-ortanylate, potassium N- (2-furylmethyl) -4-n-octylsulfonyl-5-sulfamoyl-ortanylate, potassium N- (2-furylmethyl) -4- Cyclo Lofilsulfonyl-5-sulfamoyl-ortanylate, sodium N- (2-furylmethyl) -4-cyclopropylsulfonyl-ortanylate, sodium N- (2-furylmethyl) -4-cyclobutylmethylsul Ponyl-5-sulfamoyl-ortanylate, potassium N- (2-furylmethyl) -4-cyclopentylmethylsulfonyl-5-sulfamoyl-ortanylate, sodium N- (3-furylmethyl) -4- Cyclohexylsulfonyl-5-sulfamoyl-ortanylate, sodium N- (2-thienylmethyl) -4-cycloheptylsulfonyl-5-sulfamoyl-ortanylate, potassium N- (2-furylmethyl) 4-cyclooctylsulfonyl-5-sulfamoyl-ortanylate, and sodium N- (2-furylmethyl) -5-cyclooctylmethylsulfonyl-5-sulfamoyl-ortanylate.

Claims (1)

일반식(II)의 에스테르를 알칼리성 조건하에서 비누화 시키거나, 일반식(III)의 화합물 또는 그의 염을 일반식(IV)의 아민과 반응시키거나, 일반식(V)의 화합물 또는 그의 염을 산화시킴을 특징으로하여 다음 일반식(I)의 화합물 및 그의 생리학적으로 허용되는 염을 제조하는 방법.Saponifying an ester of formula (II) under alkaline conditions, reacting a compound of formula (III) or a salt thereof with an amine of formula (IV), or oxidizing a compound of formula (V) or a salt thereof To prepare a compound of formula (I) and a physiologically acceptable salt thereof.
Figure kpo00004
Figure kpo00004
상기식에서 R은 각각 탄소수 10 이하인 알킬, 알케닐, 사이클로알킬 또는 사이클로알킬알킬이거나 페닐이고, Ar은 페닐, 티에닐 또는 푸릴이며, Z는 아릴이고, X는 할로겐이며, Y는 -S-또는 -SO-이다.Wherein R is alkyl, alkenyl, cycloalkyl or cycloalkylalkyl or phenyl each having 10 or less carbon atoms, Ar is phenyl, thienyl or furyl, Z is aryl, X is halogen, and Y is -S- or- SO-.
KR1019810000524A 1981-02-19 1981-02-19 Process for preparing 5-sulfamoyl-othanilic acids KR840002006B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019810000524A KR840002006B1 (en) 1981-02-19 1981-02-19 Process for preparing 5-sulfamoyl-othanilic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019810000524A KR840002006B1 (en) 1981-02-19 1981-02-19 Process for preparing 5-sulfamoyl-othanilic acids

Publications (2)

Publication Number Publication Date
KR830005193A KR830005193A (en) 1983-08-03
KR840002006B1 true KR840002006B1 (en) 1984-10-27

Family

ID=19220226

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019810000524A KR840002006B1 (en) 1981-02-19 1981-02-19 Process for preparing 5-sulfamoyl-othanilic acids

Country Status (1)

Country Link
KR (1) KR840002006B1 (en)

Also Published As

Publication number Publication date
KR830005193A (en) 1983-08-03

Similar Documents

Publication Publication Date Title
US4185109A (en) 1-Benzothiepin-4-carboxamides
US2734904A (en) Xcxnhxc-nh
SU626701A3 (en) Method of producing thienpyridin derivatives or their salts or their derivatives with quaternary ammonium
US3288787A (en) Substituted oxazolidinones
KR840002006B1 (en) Process for preparing 5-sulfamoyl-othanilic acids
KR910006645B1 (en) Method of producing 1,2,3-trithiane compounds
US4327224A (en) α-[(alkylamino)alkyl]-4-hydroxy-3-(alkylthio)benzenemethanols, derivatives thereof and intermediates therefor
US4665172A (en) Process for producing heterocyclic compound having nitromethylene group as the side chain group
US3860582A (en) Derivatives of 4-chloro-5-sulfamoyl-anthranilic acid
US4339446A (en) 5-Sulfamoyl-orthanilic acids, processes for their preparation and their use as medicaments
US4118501A (en) Thiazolidine derivatives
KR900003882B1 (en) Process for the preparation of compounds with h2 antihistamine activity
DE2718871A1 (en) SALIDIURETICALLY ACTIVE 5-SULFAMOYL-ORTHANILIC ACIDS AND METHOD FOR THE PRODUCTION THEREOF
US4156735A (en) Thiazolidine derivatives
EP0088252B1 (en) Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolacetoxy-acetic acid
KR100320037B1 (en) Water-stable-form kojic acid derivatives and preparation method thereof
KR810001154B1 (en) Process for preparing 5-sulfamoyl-orthanilic acids
KR890001701B1 (en) New process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives
US4277484A (en) 1-Benzothiepin-4-carboxamides
US4081453A (en) Certain 3,5-dihalo-1,2,4-thiadiazole preparations
JPS6025963A (en) Manufacture of 2-ketone sulfonamides
EP0087657B1 (en) Process for the preparation of 1-(4-chlorbenzoyl)-5-methoxy-2-methyl-3-indolylacetoxy-acetic acid
SU1203089A1 (en) Method of producing n-alkyl-2-acetonyliden-1,2-dihydroquinolines
US2517496A (en) Preparation of symmetrical monoaminodihydroxytoluene
EP0274353B1 (en) Process for the preparation of benzoin sulfonates

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right